focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHome Reit Regulatory News (HOME)

  • This share is currently suspended. It was suspended at a price of 38.014

Share Price Information for Home Reit (HOME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.014
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 38.014
HOME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Home REIT plc)

1 Mar 2023 15:43

RNS Number : 5679R
Home REIT PLC
01 March 2023
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Home REIT plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Home REIT plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

28 February 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

1p Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

0

0

(2) Cash-settled derivatives:

 

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

 

TOTAL:

0

0

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(a) Ordinary shares held by the Directors of Home REIT plc:

Home REIT Director

 

Number of Home REIT Shares

 

Percentage of Home REIT issued share capital

Simon Moore

56,000

0.00%

Lynne Fennah

55,000

0.00%

Marlene Wood

30,000

0.00%

Peter Cardwell

10,000

0.00%

TOTAL

151,000

 

0.01%

 

(b) Ordinary shares held by the Directors of Alvarium Home REIT Advisors Limited, the Investment Advisor to Home REIT plc:

 

Alvarium Home REIT Advisors Limited Director

 

Number of Home REIT Shares

 

Percentage of Home REIT issued share capital

Charlotte Fletcher

10,050

0.00%

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

1 March 2023

Contact name:

Lynne Fennah, Chairman

Telephone number:

+44 (0)20 3727 1000

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUAOVROKUORAR
Date   Source Headline
26th Apr 20229:38 amRNSHolding(s) in Company
25th Apr 20224:27 pmRNSHolding(s) in Company
21st Apr 20225:30 pmRNSHolding(s) in Company
10th Mar 202211:11 amRNSINVESTMENT ADVISER UPDATE
8th Mar 20229:24 amRNSHolding(s) in Company
9th Feb 20223:06 pmRNSPUBLICATION OF SUPPLEMENTARY PROSPECTUS
27th Jan 20223:31 pmRNSResult of AGM
27th Jan 20222:30 pmRNSDividend Declaration
25th Jan 20227:00 amRNSNET PROCEEDS OF £350M EQUITY ISSUE FULLY DEPLOYED
4th Jan 202210:17 amRNSHolding(s) in Company
23rd Dec 20212:33 pmRNSHolding(s) in Company
21st Dec 20214:44 pmRNSHolding(s) in Company
21st Dec 202110:25 amRNSHolding(s) in Company
17th Dec 20217:00 amRNSFURTHER £60M DEPLOYED FOLLOWING EQUITY ISSUE
2nd Dec 20219:44 amRNSHolding(s) in Company
2nd Dec 20217:00 amRNSNEW 15-YEAR TERM £130 MILLION DEBT FACILITY AGREED
23rd Nov 20215:57 pmRNSHolding(s) in Company
23rd Nov 20213:29 pmRNSDirector Declaration
18th Nov 20215:55 pmRNSHolding(s) in Company
17th Nov 20215:53 pmRNSHolding(s) in Company
11th Nov 20217:01 amRNSAcquisitions
11th Nov 20217:00 amRNSFinal Results
5th Nov 20211:47 pmRNSNotice of Results
1st Nov 202111:57 amRNSHolding(s) in Company
18th Oct 20217:00 amRNS£166.4 MILLION OF ACQUISITIONS
15th Oct 20213:13 pmRNSHolding(s) in Company
1st Oct 20216:09 pmRNSHolding(s) in Company - Replacement
1st Oct 20217:00 amRNSTotal Voting Rights
29th Sep 20216:08 pmRNSHolding(s) in Company
29th Sep 202111:25 amRNSHolding(s) in Company
29th Sep 202111:12 amRNSHolding(s) in Company
29th Sep 202111:05 amRNSHolding(s) in Company
28th Sep 20215:34 pmRNSHolding(s) in Company
28th Sep 20215:26 pmRNSHolding(s) in Company
28th Sep 20215:17 pmRNSHolding(s) in Company
27th Sep 20215:42 pmRNSDirector/PDMR Shareholdings
27th Sep 202111:47 amRNSHolding(s) in Company
23rd Sep 20217:00 amRNSResults of Oversubscribed Initial Issue
20th Sep 20211:15 pmRNSResult of General Meeting
17th Sep 20213:45 pmRNSHolding(s) in Company
15th Sep 20217:00 amRNSINTERIM DIVIDEND DECLARATION
2nd Sep 20215:55 pmRNSPublication of Prospectus and Circular
31st Aug 20217:01 amRNSLaunch of Issue & Placing Programme
31st Aug 20217:00 amRNSTrading Update
20th Jul 20217:00 amRNSPOTENTIAL EQUITY ISSUE
3rd Jun 20217:00 amRNSAcquisitions
20th May 20211:24 pmRNSInterim dividend declaration
18th May 20213:36 pmRNSHolding(s) in Company
11th May 202112:48 pmRNSHolding(s) in Company
28th Apr 20217:00 amRNSMaiden interim results to 28 February 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.